Abstract
Voltage-gated calcium channels are the major pathway for Ca2+ influx to initiate the contraction of smooth and cardiac muscles. Alterations of calcium channel function have been implicated in multiple cardiovascular diseases, such as hypertension, atrial fibrillation, and long QT syndrome. Post-translational modifications do expand cardiovascular calcium channel structure and function to affect processes such as channel trafficking or polyubiquitination by two E3 ubiquitin ligases, Ret finger protein 2 (Rfp2) or murine double minute 2 protein (Mdm2). Additionally, biophysical property such as Ca2+-dependent inactivation (CDI) could be altered through binding of calmodulin, or channel activity could be modulated via S-nitrosylation by nitric oxide and phosphorylation by protein kinases or by interacting protein partners, such as galectin-1 and Rem. Understanding how cardiovascular calcium channel function is post-translationally remodeled under distinctive disease conditions will provide better information about calcium channel–related disease mechanisms and improve the development of more selective therapeutic agents for cardiovascular diseases.
Similar content being viewed by others
References
Ahern BM, Levitan BM, Veeranki S, Shah M, Ali N, Sebastian A, Su W, Gong MC, Li J, Stelzer JE, Andres DA, Satin J (2019) Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice. J Biol Chem 294:10913–10927. https://doi.org/10.1074/jbc.RA119.008782
Al-Obaidi N, Mohan S, Liang S, Zhao Z, Nayak BK, Li B, Sriramarao P, Habib SL (2019) Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes. FASEB J 33:373–387. https://doi.org/10.1096/fj.201800555RR
Altier C, Garcia-Caballero A, Simms B, You H, Chen L, Walcher J, Tedford HW, Hermosilla T, Zamponi GW (2011) The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nat Neurosci 14:173–180. https://doi.org/10.1038/nn.2712
Arikkath J, Chen CC, Ahern C, Allamand V, Flanagan JD, Coronado R, Gregg RG, Campbell KP (2003) Gamma 1 subunit interactions within the skeletal muscle L-type voltage-gated calcium channels. J Biol Chem 278:1212–1219. https://doi.org/10.1074/jbc.M208689200
Astori S, Wimmer RD, Prosser HM, Corti C, Corsi M, Liaudet N, Volterra A, Franken P, Adelman JP, Luthi A (2011) The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc Natl Acad Sci U S A 108:13823–13828. https://doi.org/10.1073/pnas.1105115108
Backs J, Backs T, Neef S, Kreusser MM, Lehmann LH, Patrick DM, Grueter CE, Qi X, Richardson JA, Hill JA, Katus HA, Bassel-Duby R, Maier LS, Olson EN (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc Natl Acad Sci U S A 106:2342–2347. https://doi.org/10.1073/pnas.0813013106
Balasubramanian S, Mani S, Shiraishi H, Johnston RK, Yamane K, Willey CD, Cooper G, Tuxworth WJ, Kuppuswamy D (2006) Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases. J Mol Cell Cardiol 41:669–679. https://doi.org/10.1016/j.yjmcc.2006.04.022
Bartels P, Yu D, Huang H, Hu Z, Herzig S, Soong TW (2018) Alternative splicing at N terminus and domain I modulates CaV1.2 inactivation and surface expression. Biophys J 115:163. https://doi.org/10.1016/j.bpj.2018.06.001
Beguin P, Nagashima K, Gonoi T, Shibasaki T, Takahashi K, Kashima Y, Ozaki N, Geering K, Iwanaga T, Seino S (2001) Regulation of Ca2+ channel expression at the cell surface by the small G-protein kir/Gem. Nature 411:701–706. https://doi.org/10.1038/35079621
Ben-Johny M, Yue DT (2014) Calmodulin regulation (calmodulation) of voltage-gated calcium channels. J Gen Physiol 143:679–692. https://doi.org/10.1085/jgp.201311153
Bers DM, Morotti S (2014) Ca(2+) current facilitation is CaMKII-dependent and has arrhythmogenic consequences. Front Pharmacol 5:144. https://doi.org/10.3389/fphar.2014.00144
Birks EJ, Latif N, Enesa K, Folkvang T, le Luong A, Sarathchandra P, Khan M, Ovaa H, Terracciano CM, Barton PJ, Yacoub MH, Evans PC (2008) Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res 79:472–480. https://doi.org/10.1093/cvr/cvn083
Blaich A, Welling A, Fischer S, Wegener JW, Kostner K, Hofmann F, Moosmang S (2010) Facilitation of murine cardiac L-type Ca(v)1.2 channel is modulated by calmodulin kinase II-dependent phosphorylation of S1512 and S1570. Proc Natl Acad Sci U S A 107:10285–10289. https://doi.org/10.1073/pnas.0914287107
Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A (2005) The L-type calcium channel in the heart: the beat goes on. J Clin Invest 115:3306–3317. https://doi.org/10.1172/JCI27167
Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B (2003) Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57:55–62. https://doi.org/10.1016/s0008-6363(02)00649-1
Buraei Z, Yang J (2013) Structure and function of the beta subunit of voltage-gated Ca(2)(+) channels. Biochim Biophys Acta 1828:1530–1540. https://doi.org/10.1016/j.bbamem.2012.08.028
Burger DE, Lu X, Lei M, Xiang FL, Hammoud L, Jiang M, Wang H, Jones DL, Sims SM, Feng Q (2009) Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice. Circulation 120:1345–1354. https://doi.org/10.1161/CIRCULATIONAHA.108.846402
Burkard N, Rokita AG, Kaufmann SG, Hallhuber M, Wu R, Hu K, Hofmann U, Bonz A, Frantz S, Cartwright EJ, Neyses L, Maier LS, Maier SK, Renne T, Schuh K, Ritter O (2007) Conditional neuronal nitric oxide synthase overexpression impairs myocardial contractility. Circ Res 100:e32–e44. https://doi.org/10.1161/01.RES.0000259042.04576.6a
Campiglio M, Flucher BE (2015) The role of auxiliary subunits for the functional diversity of voltage-gated calcium channels. J Cell Physiol 230:2019–2031. https://doi.org/10.1002/jcp.24998
Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J, Bonci D, Picht E, Rusconi F, Dalton ND, Peterson KL, Richard S, Bers DM, Brown JH, Condorelli G (2009) Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. J Cell Biol 184:923–933. https://doi.org/10.1083/jcb.200805063
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411–425. https://doi.org/10.1124/pr.57.4.5
Catterall WA, Lenaeus MJ, El-Din TMG (2019) Structure and pharmacology of voltage-gated sodium and calcium channels. Annu Rev Pharmacol Toxicol. https://doi.org/10.1146/annurev-pharmtox-010818-021757
Chai S, Wan X, Ramirez-Navarro A, Tesar PJ, Kaufman ES, Ficker E, George AL Jr, Deschenes I (2018) Physiological genomics identifies genetic modifiers of long QT syndrome type 2 severity. J Clin Invest 128:1043–1056. https://doi.org/10.1172/JCI94996
Chazin WJ, Johnson CN (2020) Calmodulin mutations associated with heart arrhythmia: a status report. Int J Mol Sci:21. https://doi.org/10.3390/ijms21041418
Chen X, Nakayama H, Zhang X, Ai X, Harris DM, Tang M, Zhang H, Szeto C, Stockbower K, Berretta RM, Eckhart AD, Koch WJ, Molkentin JD, Houser SR (2011) Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy. J Mol Cell Cardiol 50:460–470. https://doi.org/10.1016/j.yjmcc.2010.11.012
Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, Chen YC, Chen YH, Shin HS, Campbell KP, Chen CC (2009) The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 104:522–530. https://doi.org/10.1161/CIRCRESAHA.108.184051
Cribbs LL (2006) T-type Ca2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40:221–230. https://doi.org/10.1016/j.ceca.2006.04.026
Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kaab S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ, George AL Jr (2013) Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation 127:1009–1017. https://doi.org/10.1161/CIRCULATIONAHA.112.001216
Crotti L, Spazzolini C, Tester DJ, Ghidoni A, Baruteau AE, Beckmann BM, Behr ER, Bennett JS, Bezzina CR, Bhuiyan ZA, Celiker A, Cerrone M, Dagradi F, De Ferrari GM, Etheridge SP, Fatah M, Garcia-Pavia P, Al-Ghamdi S, Hamilton RM, Al-Hassnan ZN, Horie M, Jimenez-Jaimez J, Kanter RJ, Kaski JP, Kotta MC, Lahrouchi N, Makita N, Norrish G, Odland HH, Ohno S, Papagiannis J, Parati G, Sekarski N, Tveten K, Vatta M, Webster G, Wilde AAM, Wojciak J, George AL, Ackerman MJ, Schwartz PJ (2019) Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry. Eur Heart J 40:2964–2975. https://doi.org/10.1093/eurheartj/ehz311
David LS, Garcia E, Cain SM, Thau E, Tyson JR, Snutch TP (2010) Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development. Channels (Austin) 4:375–389. https://doi.org/10.4161/chan.4.5.12874
Dick IE, Tadross MR, Liang H, Tay LH, Yang W, Yue DT (2008) A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of CaV channels. Nature 451:830–834. https://doi.org/10.1038/nature06529
Dolphin AC (2006) A short history of voltage-gated calcium channels. Br J Pharmacol 147(Suppl 1):S56–S62. https://doi.org/10.1038/sj.bjp.0706442
Ebner J, Cagalinec M, Kubista H, Todt H, Szabo PL, Kiss A, Podesser BK, Cserne Szappanos H, Hool LC, Hilber K, Koenig X (2020) Neuronal nitric oxide synthase regulation of calcium cycling in ventricular cardiomyocytes is independent of Cav1.2 channel modulation under basal conditions. Pflugers Arch 472:61–74. https://doi.org/10.1007/s00424-019-02335-7
Fan J, Fan W, Lei J, Zhou Y, Xu H, Kapoor I, Zhu G, Wang J (2019) Galectin-1 attenuates cardiomyocyte hypertrophy through splice-variant specific modulation of CaV1.2 calcium channel. Biochim Biophys Acta Mol basis Dis 1865:218–229. https://doi.org/10.1016/j.bbadis.2018.08.016
Fang K, Colecraft HM (2011) Mechanism of auxiliary beta-subunit-mediated membrane targeting of L-type (Ca(V)1.2) channels. J Physiol 589:4437–4455. https://doi.org/10.1113/jphysiol.2011.214247
Finlin BS, Shao H, Kadono-Okuda K, Guo N, Andres DA (2000) Rem2, a new member of the Rem/Rad/Gem/Kir family of Ras-related GTPases. Biochem J 347(Pt 1):223–231
Finlin BS, Crump SM, Satin J, Andres DA (2003) Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases. Proc Natl Acad Sci U S A 100:14469–14474. https://doi.org/10.1073/pnas.2437756100
Franssen C, Chen S, Unger A, Korkmaz HI, De Keulenaer GW, Tschope C, Leite-Moreira AF, Musters R, Niessen HW, Linke WA, Paulus WJ, Hamdani N (2016) Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction. JACC Heart Fail 4:312–324. https://doi.org/10.1016/j.jchf.2015.10.007
Freitag N, Tirado-Gonzalez I, Barrientos G, Herse F, Thijssen VL, Weedon-Fekjaer SM, Schulz H, Wallukat G, Klapp BF, Nevers T, Sharma S, Staff AC, Dechend R, Blois SM (2013) Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia. Proc Natl Acad Sci U S A 110:11451–11456. https://doi.org/10.1073/pnas.1303707110
Fu Y, Westenbroek RE, Scheuer T, Catterall WA (2014) Basal and beta-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700. Proc Natl Acad Sci U S A 111:16598–16603. https://doi.org/10.1073/pnas.1419129111
Gadotti VM, Caballero AG, Berger ND, Gladding CM, Chen L, Pfeifer TA, Zamponi GW (2015) Small organic molecule disruptors of Cav3.2-USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain 11:12. https://doi.org/10.1186/s12990-015-0011-8
Garcia-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, Deage M, Francois A, Bourinet E, Zamponi GW (2014) The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron 83:1144–1158. https://doi.org/10.1016/j.neuron.2014.07.036
Glukhov AV, Balycheva M, Sanchez-Alonso JL, Ilkan Z, Alvarez-Laviada A, Bhogal N, Diakonov I, Schobesberger S, Sikkel MB, Bhargava A, Faggian G, Punjabi PP, Houser SR, Gorelik J (2015) Direct evidence for microdomain-specific localization and remodeling of functional L-type calcium channels in rat and human atrial myocytes. Circulation 132:2372–2384. https://doi.org/10.1161/CIRCULATIONAHA.115.018131
Gonzalez DR, Treuer A, Sun QA, Stamler JS, Hare JM (2009) S-Nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol 54:188–195. https://doi.org/10.1097/FJC.0b013e3181b72c9f
Goonasekera SA, Hammer K, Auger-Messier M, Bodi I, Chen X, Zhang H, Reiken S, Elrod JW, Correll RN, York AJ, Sargent MA, Hofmann F, Moosmang S, Marks AR, Houser SR, Bers DM, Molkentin JD (2012) Decreased cardiac L-type Ca(2)(+) channel activity induces hypertrophy and heart failure in mice. J Clin Invest 122:280–290. https://doi.org/10.1172/jci58227
Grant AO (2009) Cardiac ion channels. Circ Arrhythm Electrophysiol 2:185–194. https://doi.org/10.1161/CIRCEP.108.789081
Harraz OF, Welsh DG (2013) Protein kinase A regulation of T-type Ca2+ channels in rat cerebral arterial smooth muscle. J Cell Sci 126:2944–2954. https://doi.org/10.1242/jcs.128363
Hauck L, Stanley-Hasnain S, Fung A, Grothe D, Rao V, Mak TW, Billia F (2017) Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death. PLoS One 12:e0189861. https://doi.org/10.1371/journal.pone.0189861
Hofmann F, Flockerzi V, Kahl S, Wegener JW (2014) L-type CaV1.2 calcium channels: from in vitro findings to in vivo function. Physiol Rev 94:303–326. https://doi.org/10.1152/physrev.00016.2013
Hong TT, Smyth JW, Gao D, Chu KY, Vogan JM, Fong TS, Jensen BC, Colecraft HM, Shaw RM (2010) BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol 8:e1000312. https://doi.org/10.1371/journal.pbio.1000312
Hong TT, Smyth JW, Chu KY, Vogan JM, Fong TS, Jensen BC, Fang K, Halushka MK, Russell SD, Colecraft H, Hoopes CW, Ocorr K, Chi NC, Shaw RM (2012) BIN1 is reduced and Cav1.2 trafficking is impaired in human failing cardiomyocytes. Heart Rhythm 9:812–820. https://doi.org/10.1016/j.hrthm.2011.11.055
Hu C, Depuy SD, Yao J, McIntire WE, Barrett PQ (2009) Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers. J Biol Chem 284:7465–7473. https://doi.org/10.1074/jbc.M808049200
Hu Z, Liang MC, Soong TW (2017) Alternative splicing of L-type CaV1.2 calcium channels: implications in cardiovascular diseases. Genes (Basel) 8. https://doi.org/10.3390/genes8120344
Hu Z, Li G, Wang JW, Chong SY, Yu D, Wang X, Soon JL, Liang MC, Wong YP, Huang N, Colecraft HM, Liao P, Soong TW (2018) Regulation of blood pressure by targeting CaV1.2-galectin-1 protein interaction. Circulation 138:1431–1445. https://doi.org/10.1161/CIRCULATIONAHA.117.031231
Huang B, Qin D, Deng L, Boutjdir M, E-S N (2000) Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle. Cardiovasc Res 46:442–449. https://doi.org/10.1016/s0008-6363(00)00017-1
Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS (2005) CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J Cell Biol 171:537–547. https://doi.org/10.1083/jcb.200505155
Izumi T, Kihara Y, Sarai N, Yoneda T, Iwanaga Y, Inagaki K, Onozawa Y, Takenaka H, Kita T, Noma A (2003) Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 108:2530–2535. https://doi.org/10.1161/01.CIR.0000096484.03318.AB
Jensen HH, Brohus M, Nyegaard M, Overgaard MT (2018) Human calmodulin mutations. Front Mol Neurosci 11:396. https://doi.org/10.3389/fnmol.2018.00396
Jones SP, Greer JJ, van Haperen R, Duncker DJ, de Crom R, Lefer DJ (2003) Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A 100:4891–4896. https://doi.org/10.1073/pnas.0837428100
Katchman A, Yang L, Zakharov SI, Kushner J, Abrams J, Chen BX, Liu G, Pitt GS, Colecraft HM, Marx SO (2017) Proteolytic cleavage and PKA phosphorylation of alpha1C subunit are not required for adrenergic regulation of CaV1.2 in the heart. Proc Natl Acad Sci U S A 114:9194–9199. https://doi.org/10.1073/pnas.1706054114
Kharade SV, Sonkusare SK, Srivastava AK, Thakali KM, Fletcher TW, Rhee SW, Rusch NJ (2013) The beta3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice. Hypertension 61:137–142. https://doi.org/10.1161/HYPERTENSIONAHA.112.197863
Kim JA, Park JY, Kang HW, Huh SU, Jeong SW, Lee JH (2006) Augmentation of Cav3.2 T-type calcium channel activity by cAMP-dependent protein kinase A. J Pharmacol Exp Ther 318:230–237. https://doi.org/10.1124/jpet.106.101402
Koval OM, Guan X, Wu Y, Joiner ML, Gao Z, Chen B, Grumbach IM, Luczak ED, Colbran RJ, Song LS, Hund TJ, Mohler PJ, Anderson ME (2010) CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc Natl Acad Sci U S A 107:4996–5000. https://doi.org/10.1073/pnas.0913760107
Lai YJ, Zhu BL, Sun F, Luo D, Ma YL, Luo B, Tang J, Xiong MJ, Liu L, Long Y, Hu XT, He L, Deng XJ, Zhang JH, Yang J, Yan Z, Chen GJ (2019) Estrogen receptor alpha promotes Cav1.2 ubiquitination and degradation in neuronal cells and in APP/PS1 mice. Aging Cell 18:e12961. https://doi.org/10.1111/acel.12961
Lemke T, Welling A, Christel CJ, Blaich A, Bernhard D, Lenhardt P, Hofmann F, Moosmang S (2008) Unchanged beta-adrenergic stimulation of cardiac L-type calcium channels in Ca v 1.2 phosphorylation site S1928A mutant mice. J Biol Chem 283:34738–34744. https://doi.org/10.1074/jbc.M804981200
Lerner M, Corcoran M, Cepeda D, Nielsen ML, Zubarev R, Ponten F, Uhlen M, Hober S, Grander D, Sangfelt O (2007) The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell 18:1670–1682. https://doi.org/10.1091/mbc.e06-03-0248
Li Y, Wang F, Zhang X, Qi Z, Tang M, Szeto C, Li Y, Zhang H, Chen X (2012) beta-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. PLoS One 7:e39965. https://doi.org/10.1371/journal.pone.0039965
Li G, Wang J, Liao P, Bartels P, Zhang H, Yu D, Liang MC, Poh KK, Yu CY, Jiang F, Yong TF, Wong YP, Hu Z, Huang H, Zhang G, Galupo MJ, Bian JS, Ponniah S, Trasti SL, See K, Foo R, Hoppe UC, Herzig S, Soong TW (2017) Exclusion of alternative exon 33 of CaV1.2 calcium channels in heart is proarrhythmogenic. Proc Natl Acad Sci U S A 114:E4288–E4295. https://doi.org/10.1073/pnas.1617205114
Li Y, Zhang X, Zhang C, Zhang X, Li Y, Qi Z, Szeto C, Tang M, Peng Y, Molkentin JD, Houser SR, Xie M, Chen X (2018) Increasing T-type calcium channel activity by beta-adrenergic stimulation contributes to beta-adrenergic regulation of heart rates. J Physiol 596:1137–1151. https://doi.org/10.1113/JP274756
Liao P, Yong TF, Liang MC, Yue DT, Soong TW (2005) Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. Cardiovasc Res 68:197–203. https://doi.org/10.1016/j.cardiores.2005.06.024
Liao P, Yu D, Hu Z, Liang MC, Wang JJ, Yu CY, Ng G, Yong TF, Soon JL, Chua YL, Soong TW (2015) Alternative splicing generates a novel truncated Cav1.2 channel in neonatal rat heart. J Biol Chem 290:9262–9272. https://doi.org/10.1074/jbc.M114.594911
Lim GB (2019) New mouse model reveals nitrosative stress as a novel driver of HFpEF. Nat Rev Cardiol 16:383. https://doi.org/10.1038/s41569-019-0203-4
Limpitikul WB, Dick IE, Joshi-Mukherjee R, Overgaard MT, George AL Jr, Yue DT (2014) Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes. J Mol Cell Cardiol 74:115–124. https://doi.org/10.1016/j.yjmcc.2014.04.022
Limpitikul WB, Dick IE, Tester DJ, Boczek NJ, Limphong P, Yang W, Choi MH, Babich J, DiSilvestre D, Kanter RJ, Tomaselli GF, Ackerman MJ, Yue DT (2017) A precision medicine approach to the rescue of function on malignant calmodulinopathic long-QT syndrome. Circ Res 120:39–48. https://doi.org/10.1161/CIRCRESAHA.116.309283
Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu Y, Dalton ND, Peterson KL, Chen J, Bers D, Brown JH (2009) Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 119:1230–1240. https://doi.org/10.1172/JCI38022
Link S, Meissner M, Held B, Beck A, Weissgerber P, Freichel M, Flockerzi V (2009) Diversity and developmental expression of L-type calcium channel beta2 proteins and their influence on calcium current in murine heart. J Biol Chem 284:30129–30137. https://doi.org/10.1074/jbc.M109.045583
Liu Z, Vogel HJ (2012) Structural basis for the regulation of L-type voltage-gated calcium channels: interactions between the N-terminal cytoplasmic domain and Ca(2+)-calmodulin. Front Mol Neurosci 5:38. https://doi.org/10.3389/fnmol.2012.00038
Liu C, Zhang CW, Lo SQ, Ang ST, Chew KCM, Yu D, Chai BH, Tan B, Tsang F, Tai YK, Tan BWQ, Liang MC, Tan HT, Tang JY, Lai MKP, Chua JJE, Chung MCM, Khanna S, Lim KL, Soong TW (2018) S-Nitrosylation of divalent metal transporter 1 enhances iron uptake to mediate loss of dopaminergic neurons and motoric deficit. J Neurosci 38:8364–8377. https://doi.org/10.1523/JNEUROSCI.3262-17.2018
Liu G, Papa A, Katchman AN, Zakharov SI, Roybal D, Hennessey JA, Kushner J, Yang L, Chen BX, Kushnir A, Dangas K, Gygi SP, Pitt GS, Colecraft HM, Ben-Johny M, Kalocsay M, Marx SO (2020) Mechanism of adrenergic CaV1.2 stimulation revealed by proximity proteomics. Nature 577:695–700. https://doi.org/10.1038/s41586-020-1947-z
Lundby A, Andersen MN, Steffensen AB, Horn H, Kelstrup CD, Francavilla C, Jensen LJ, Schmitt N, Thomsen MB, Olsen JV (2013) In vivo phosphoproteomics analysis reveals the cardiac targets of beta-adrenergic receptor signaling. Sci Signal 6:rs11. https://doi.org/10.1126/scisignal.2003506
Magyar J, Kiper CE, Sievert G, Cai W, Shi GX, Crump SM, Li L, Niederer S, Smith N, Andres DA, Satin J (2012) Rem-GTPase regulates cardiac myocyte L-type calcium current. Channels (Austin) 6:166–173. https://doi.org/10.4161/chan.20192
Makarewich CA, Correll RN, Gao H, Zhang H, Yang B, Berretta RM, Rizzo V, Molkentin JD, Houser SR (2012) A caveolae-targeted L-type Ca(2)+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility. Circ Res 110:669–674. https://doi.org/10.1161/CIRCRESAHA.111.264028
Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J (2003) Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc Natl Acad Sci U S A 100:5543–5548. https://doi.org/10.1073/pnas.0935295100
Marionneau C, Couette B, Liu J, Li H, Mangoni ME, Nargeot J, Lei M, Escande D, Demolombe S (2005) Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562:223–234. https://doi.org/10.1113/jphysiol.2004.074047
Markandeya YS, Phelan LJ, Woon MT, Keefe AM, Reynolds CR, August BK, Hacker TA, Roth DM, Patel HH, Balijepalli RC (2015) Caveolin-3 overexpression attenuates cardiac hypertrophy via inhibition of T-type Ca2+ current modulated by protein kinase Calpha in cardiomyocytes. J Biol Chem 290:22085–22100. https://doi.org/10.1074/jbc.M115.674945
McHugh D, Sharp EM, Scheuer T, Catterall WA (2000) Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proc Natl Acad Sci U S A 97:12334–12338. https://doi.org/10.1073/pnas.210384297
Mearini G, Schlossarek S, Willis MS, Carrier L (2008) The ubiquitin-proteasome system in cardiac dysfunction. Biochim Biophys Acta 1782:749–763. https://doi.org/10.1016/j.bbadis.2008.06.009
Mesubi OO, Anderson ME (2016) Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovasc Res 109:542–557. https://doi.org/10.1093/cvr/cvw002
Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N (2003) Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 22:6027–6034. https://doi.org/10.1093/emboj/cdg583
Nakayama H, Bodi I, Correll RN, Chen X, Lorenz J, Houser SR, Robbins J, Schwartz A, Molkentin JD (2009) alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 119:3787–3796. https://doi.org/10.1172/JCI39724
Nystoriak MA, Nieves-Cintron M, Patriarchi T, Buonarati OR, Prada MP, Morotti S, Grandi E, Fernandes JD, Forbush K, Hofmann F, Sasse KC, Scott JD, Ward SM, Hell JW, Navedo MF (2017) Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes. Sci Signal 10. https://doi.org/10.1126/scisignal.aaf9647
Obata K, Nagata K, Iwase M, Odashima M, Nagasaka T, Izawa H, Murohara T, Yamada Y, Yokota M (2005) Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway. Biochem Biophys Res Commun 338:1299–1305. https://doi.org/10.1016/j.bbrc.2005.10.083
Packer M, Carson P, Elkayam U, Konstam MA, Moe G, O’Connor C, Rouleau JL, Schocken D, Anderson SA, DeMets DL, Group P-S (2013) Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2). JACC Heart Fail 1:308–314. https://doi.org/10.1016/j.jchf.2013.04.004
Pang C, Crump SM, Jin L, Correll RN, Finlin BS, Satin J, Andres DA (2010) Rem GTPase interacts with the proximal CaV1.2 C-terminus and modulates calcium-dependent channel inactivation. Channels (Austin) 4:192–202. https://doi.org/10.4161/chan.4.3.11867
Patriarchi T, Qian H, Di Biase V, Malik ZA, Chowdhury D, Price JL, Hammes EA, Buonarati OR, Westenbroek RE, Catterall WA, Hofmann F, Xiang YK, Murphy GG, Chen CY, Navedo MF, Hell JW (2016) Phosphorylation of Cav1.2 on S1928 uncouples the L-type Ca2+ channel from the beta2 adrenergic receptor. EMBO J 35:1330–1345. https://doi.org/10.15252/embj.201593409
Paulus WJ (2020) Unfolding discoveries in heart failure. N Engl J Med 382:679–682. https://doi.org/10.1056/NEJMcibr1913825
Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271. https://doi.org/10.1016/j.jacc.2013.02.092
Pipilas DC, Johnson CN, Webster G, Schlaepfer J, Fellmann F, Sekarski N, Wren LM, Ogorodnik KV, Chazin DM, Chazin WJ, Crotti L, Bhuiyan ZA, George AL Jr (2016) Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes. Heart Rhythm 13:2012–2019. https://doi.org/10.1016/j.hrthm.2016.06.038
Puckerin AA, Chang DD, Subramanyam P, Colecraft HM (2016) Similar molecular determinants on Rem mediate two distinct modes of inhibition of CaV1.2 channels. Channels (Austin) 10:379–394. https://doi.org/10.1080/19336950.2016.1180489
Puckerin AA, Chang DD, Shuja Z, Choudhury P, Scholz J, Colecraft HM (2018) Engineering selectivity into RGK GTPase inhibition of voltage-dependent calcium channels. Proc Natl Acad Sci U S A 115:12051–12056. https://doi.org/10.1073/pnas.1811024115
Raifman TK, Kumar P, Haase H, Klussmann E, Dascal N, Weiss S (2017) Protein kinase C enhances plasma membrane expression of cardiac L-type calcium channel, CaV1.2. Channels (Austin) 11:604–615. https://doi.org/10.1080/19336950.2017.1369636
Rokita AG, Anderson ME (2012) New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII). Circulation 126:2125–2139. https://doi.org/10.1161/CIRCULATIONAHA.112.124990
Rusconi F, Ceriotti P, Miragoli M, Carullo P, Salvarani N, Rocchetti M, Di Pasquale E, Rossi S, Tessari M, Caprari S, Cazade M, Kunderfranco P, Chemin J, Bang ML, Polticelli F, Zaza A, Faggian G, Condorelli G, Catalucci D (2016) Peptidomimetic targeting of Cavbeta2 overcomes dysregulation of the L-type calcium channel density and recovers cardiac function. Circulation 134:534–546. https://doi.org/10.1161/CIRCULATIONAHA.116.021347
Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444–448. https://doi.org/10.1038/nature05602
Santulli G, Nakashima R, Yuan Q, Marks AR (2017) Intracellular calcium release channels: an update. J Physiol 595:3041–3051. https://doi.org/10.1113/JP272781
Schiattarella GG, Altamirano F, Tong D, French KM, Villalobos E, Kim SY, Luo X, Jiang N, May HI, Wang ZV, Hill TM, Mammen PPA, Huang J, Lee DI, Hahn VS, Sharma K, Kass DA, Lavandero S, Gillette TG, Hill JA (2019) Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568:351–356. https://doi.org/10.1038/s41586-019-1100-z
Seropian IM, Cerliani JP, Toldo S, Van Tassell BW, Ilarregui JM, Gonzalez GE, Matoso M, Salloum FN, Melchior R, Gelpi RJ, Stupirski JC, Benatar A, Gomez KA, Morales C, Abbate A, Rabinovich GA (2013) Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am J Pathol 182:29–40. https://doi.org/10.1016/j.ajpath.2012.09.022
Seropian IM, Gonzalez GE, Maller SM, Berrocal DH, Abbate A, Rabinovich GA (2018) Galectin-1 as an emerging mediator of cardiovascular inflammation: mechanisms and therapeutic opportunities. Mediat Inflamm 2018:8696543. https://doi.org/10.1155/2018/8696543
Sica DA (2006) Pharmacotherapy review: calcium channel blockers. J Clin Hypertens (Greenwich) 8:53–56. https://doi.org/10.1111/j.1524-6175.2005.04140.x
Simms BA, Souza IA, Rehak R, Zamponi GW (2015) The Cav1.2 N terminus contains a CaM kinase site that modulates channel trafficking and function. Pflugers Arch 467:677–686. https://doi.org/10.1007/s00424-014-1538-7
Song LS, Guia A, Muth JN, Rubio M, Wang SQ, Xiao RP, Josephson IR, Lakatta EG, Schwartz A, Cheng H (2002) Ca(2+) signaling in cardiac myocytes overexpressing the alpha(1) subunit of L-type Ca(2+) channel. Circ Res 90:174–181
Stamler JS, Hess DT (2010) Nascent nitrosylases. Nat Cell Biol 12:1024–1026. https://doi.org/10.1038/ncb1110-1024
Stamler JS, Toone EJ, Lipton SA, Sucher NJ (1997) (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18:691–696. https://doi.org/10.1016/s0896-6273(00)80310-4
Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P (2014) L-type Ca(2+) channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal 3:15–38. https://doi.org/10.1002/wmts.102
Sun J, Picht E, Ginsburg KS, Bers DM, Steenbergen C, Murphy E (2006) Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res 98:403–411. https://doi.org/10.1161/01.RES.0000202707.79018.0a
Swaminathan PD, Purohit A, Hund TJ, Anderson ME (2012) Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 110:1661–1677. https://doi.org/10.1161/CIRCRESAHA.111.243956
Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, Bayliss DA (1999) Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19:1895–1911
Wang X, Tsien RW (2020) Suspect that modulates the heartbeat is ensnared. Nature 577:624–626. https://doi.org/10.1038/d41586-020-00096-3
Wang J, Thio SS, Yang SS, Yu D, Yu CY, Wong YP, Liao P, Li S, Soong TW (2011) Splice variant specific modulation of CaV1.2 calcium channel by galectin-1 regulates arterial constriction. Circ Res 109:1250–1258. https://doi.org/10.1161/CIRCRESAHA.111.248849
Wang S, Stanika RI, Wang X, Hagen J, Kennedy MB, Obermair GJ, Colbran RJ, Lee A (2017) Densin-180 controls the trafficking and signaling of L-type voltage-gated Cav1.2 Ca(2+) channels at excitatory synapses. J Neurosci 37:4679–4691. https://doi.org/10.1523/JNEUROSCI.2583-16.2017
Weiss S, Keren-Raifman T, Oz S, Ben Mocha A, Haase H, Dascal N (2012) Modulation of distinct isoforms of L-type calcium channels by G(q)-coupled receptors in Xenopus oocytes: antagonistic effects of Gbetagamma and protein kinase C. Channels (Austin) 6:426–437. https://doi.org/10.4161/chan.22016
Wu Y, Temple J, Zhang R, Dzhura I, Zhang W, Trimble R, Roden DM, Passier R, Olson EN, Colbran RJ, Anderson ME (2002) Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 106:1288–1293. https://doi.org/10.1161/01.cir.0000027583.73268.e7
Xu L, Lai D, Cheng J, Lim HJ, Keskanokwong T, Backs J, Olson EN, Wang Y (2010) Alterations of L-type calcium current and cardiac function in CaMKII{delta} knockout mice. Circ Res 107:398–407. https://doi.org/10.1161/CIRCRESAHA.110.222562
Xu X, Marx SO, Colecraft HM (2010) Molecular mechanisms, and selective pharmacological rescue, of Rem-inhibited CaV1.2 channels in heart. Circ Res 107:620–630. https://doi.org/10.1161/CIRCRESAHA.110.224717
Yang T, Colecraft HM (2013) Regulation of voltage-dependent calcium channels by RGK proteins. Biochim Biophys Acta 1828:1644–1654. https://doi.org/10.1016/j.bbamem.2012.10.005
Yang L, Liu G, Zakharov SI, Morrow JP, Rybin VO, Steinberg SF, Marx SO (2005) Ser1928 is a common site for Cav1.2 phosphorylation by protein kinase C isoforms. J Biol Chem 280:207–214. https://doi.org/10.1074/jbc.M410509200
Yang L, Liu G, Zakharov SI, Bellinger AM, Mongillo M, Marx SO (2007) Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits. Circ Res 101:465–474. https://doi.org/10.1161/CIRCRESAHA.107.156976
Yang T, Xu X, Kernan T, Wu V, Colecraft HM (2010) Rem, a member of the RGK GTPases, inhibits recombinant CaV1.2 channels using multiple mechanisms that require distinct conformations of the GTPase. J Physiol 588:1665–1681. https://doi.org/10.1113/jphysiol.2010.187203
Yang L, Katchman A, Morrow JP, Doshi D, Marx SO (2011) Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J 25:928–936. https://doi.org/10.1096/fj.10-172353
Yang L, Dai DF, Yuan C, Westenbroek RE, Yu H, West N, de la Iglesia HO, Catterall WA (2016) Loss of beta-adrenergic-stimulated phosphorylation of CaV1.2 channels on Ser1700 leads to heart failure. Proc Natl Acad Sci U S A 113:E7976–E7985. https://doi.org/10.1073/pnas.1617116113
Yang L, Katchman A, Kushner J, Kushnir A, Zakharov SI, Chen BX, Shuja Z, Subramanyam P, Liu G, Papa A, Roybal D, Pitt GS, Colecraft HM, Marx SO (2019) Cardiac CaV1.2 channels require beta subunits for beta-adrenergic-mediated modulation but not trafficking. J Clin Invest 129:647–658. https://doi.org/10.1172/JCI123878
Yoon S, Kim M, Lee H, Kang G, Nam K, Kook H, Eom GH (2019) Cardiac nitric oxide synthase 1 worsens heart failure with preserved ejection fraction through S-nitrosylation of histone deacetylase 2. bioRxiv:708297. https://doi.org/10.1101/708297
Yuan Y, Zhao J, Gong Y, Wang D, Wang X, Yun F, Liu Z, Zhang S, Li W, Zhao X, Sun L, Sheng L, Pan Z, Li Y (2018) Autophagy exacerbates electrical remodeling in atrial fibrillation by ubiquitin-dependent degradation of L-type calcium channel. Cell Death Dis 9:873. https://doi.org/10.1038/s41419-018-0860-y
Zhang T, Maier LS, Dalton ND, Miyamoto S, Ross J Jr, Bers DM, Brown JH (2003) The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 92:912–919. https://doi.org/10.1161/01.RES.0000069686.31472.C5
Zhang Z, He Y, Tuteja D, Xu D, Timofeyev V, Zhang Q, Glatter KA, Xu Y, Shin HS, Low R, Chiamvimonvat N (2005) Functional roles of Cav1.3(alpha1D) calcium channels in atria: insights gained from gene-targeted null mutant mice. Circulation 112:1936–1944. https://doi.org/10.1161/CIRCULATIONAHA.105.540070
Zhang P, Xu X, Hu X, van Deel ED, Zhu G, Chen Y (2007) Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 100:1089–1098. https://doi.org/10.1161/01.RES.0000264081.78659.45
Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y, Zhang C, Tang M, Szeto C, Hua X, Xie M, Zeng C, Wu Y, Zhou L, Zhu W, Yu D, Houser SR, Chen X (2019) Cardiomyocyte PKA ablation enhances basal contractility while eliminates cardiac beta-adrenergic response without adverse effects on the heart. Circ Res 124:1760–1777. https://doi.org/10.1161/CIRCRESAHA.118.313417
Zhao XY, Chen TT, Xia L, Guo M, Xu Y, Yue F, Jiang Y, Chen GQ, Zhao KW (2010) Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells. Carcinogenesis 31:1367–1375. https://doi.org/10.1093/carcin/bgq116
Zhou MH, Bavencoffe A, Pan HL (2015) Molecular basis of regulating high voltage-activated calcium channels by S-nitrosylation. J Biol Chem 290:30616–30623. https://doi.org/10.1074/jbc.M115.685206
Zuccotti A, Clementi S, Reinbothe T, Torrente A, Vandael DH, Pirone A (2011) Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting. Trends Pharmacol Sci 32:366–375. https://doi.org/10.1016/j.tips.2011.02.012
Carnes CA, Janssen PML, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, Hamlin RL, Van Wagoner DR (2007) Atrial glutathione content, calcium current, and contractility. J Biol Chem 282(38):28063–28073
Funding
This work received funding from the Academic Research Fund (AcRF) tier 2 grant from Singapore Ministry of Education (to T.W.S.), Singapore Ministry of Education NUSMed post-doctoral fellowship (to Z.H.), and NGS PhD scholarship from the National University of Singapore (to K.W.Z.L.).
Author information
Authors and Affiliations
Contributions
Z.H. and K.W.Z.L. wrote the manuscript with input from M.C.L. (figure/table preparation). T.W.S. critically edited the manuscript. All authors approved the final version of the manuscript.
Corresponding authors
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Loh, K.W.Z., Liang, M.C., Soong, T.W. et al. Regulation of cardiovascular calcium channel activity by post-translational modifications or interacting proteins. Pflugers Arch - Eur J Physiol 472, 653–667 (2020). https://doi.org/10.1007/s00424-020-02398-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-020-02398-x